Blood problems after Velagliflozin (Senvelgo) in cats

44 reports to the FDA describe blood problems in cats given Velagliflozin. That is 0.9% of all reports for this medicine, compared with 1.9% across reports for all cat medicines, so it is reported less often than average with this medicine.

44Reports

68%Marked serious

0.0%Recovered

32%Died or euthanised

20 daysTypical onset

How soon it started

Same day

2 6.1%

1–2 days

6 18%

3–7 days

6 18%

1–4 weeks

6 18%

Over a month

13 39%

How the animals did

Still unwell when reported

7 16%

Died

5 11%

Euthanised

9 20%

Not known

23 52%

Problems reported at the same time

24 55%

21 48%

21 48%

17 39%

15 34%

14 32%

14 32%

12 27%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Velagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).

Products with this ingredient include Senvelgo. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Velagliflozin cause blood problems in cats?: 44 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 20 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Blood problems with similar medicines

Blood problems after Bexagliflozin (Bexacat) 68 reports · 1.7% of its reports
Blood problems after Insulin 56 reports · 1.5% of its reports
Blood problems after Methimazole 99 reports · 5.6% of its reports

All reported side effects of Velagliflozin in cats · Medicines most reported with blood problems